FWP 1 d295887dfwp.htm TERM SHEET Term Sheet

Term Sheet

(To Prospectus dated April 20, 2009, Series L Prospectus

Supplement dated April 21, 2009, and Product Supplement

CLN-2 dated December 29, 2009)

February 6, 2012

 

Filed Pursuant to Rule 433

Registration No. 333-158663

 

LOGO

Commodity-Linked Notes Linked to the Dow Jones-UBS Commodity IndexSM Total Return,

due March 8, 2013

 

Issuer:

   Bank of America Corporation
Pricing Date:    February 6, 2012
Issue Date:    February 13, 2012
Stated Maturity Date:    March 8, 2013
Aggregate Principal Amount:    $2,800,000
Underlying Index:    The Dow Jones-UBS Commodity IndexSM Total Return (Bloomberg symbol: “DJUBSTR”)
Starting Value:    TBD
Ending Value:    The closing level of the Underlying Index on the Valuation Date. If it is determined that the scheduled Valuation Date is not an Index Business Day, or if a Market Disruption Event occurs on the scheduled Valuation Date, the Ending Value will be determined as more fully described beginning on page S-27 of product supplement CLN-2.
Leverage Factor:    3
Investor Fee:    The greater of (a) the fixed percentage of 0.00% and (b) a percentage equal to 0.35% per annum, as described beginning on page S-18 of product supplement CLN-2 under “Description of the Notes—Payment at Maturity.”
Treasury Rate Charge:    Applicable
Interest Rate Basis:    LIBOR

Designated Maturity:

   One Month

Interest Reset Dates:

   The 8th of each calendar month, commencing on March 8, 2012.

Interest Payment Dates:

   Unless the Notes are redeemed on an earlier date, interest will be payable only at maturity.
Spread:    Plus 0 basis points
Initial Optional Redemption Date:    February 13, 2012
Upper Mandatory Redemption Trigger Level:    Not Applicable
Lower Mandatory Redemption Trigger Level:    85% of the Starting Value
NPV Factor:    Not Applicable
Bear Note:    No
Calculation Agent:    Merrill Lynch Commodities, Inc.
Listing:    No listing on any securities exchange.
CUSIP:    06048WKP4

 

                     Per  Note                          Total          

Public Offering Price(1)

   $ 100,000       $ 2,800,000   

Underwriting Discount

   $ 0       $ 0   

Proceeds, before expenses, to Bank of America Corporation

   $ 100,000       $ 2,800,000   
  (1) 

Plus accrued interest from February 13, 2012 if settlement occurs after that date.

 

 

The Notes are unsecured and are not savings accounts, deposits, or other obligations of a bank. The Notes are not guaranteed by Bank of America, N.A. or any other bank, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and involve investment risks. Potential purchasers of the Notes should consider the information in “Risk Factors” beginning on page S-8 of the product supplement, page S-4 of the attached prospectus supplement, and page 8 of the attached prospectus

None of the Securities and Exchange Commission (the “SEC”), any state securities commission, or any other regulatory body has approved or disapproved of these Notes or passed upon the adequacy or accuracy of this tem sheet, the product supplement, the prospectus supplement, or the prospectus. Any representation to the contrary is a criminal offense.

 

 

In connection with this offering, Merrill Lynch, Pierce, Fenner & Smith Incorporated (“MLPF&S”) is acting in its capacity as principal for your account. We will deliver the Notes in book-entry form only through The Depository Trust Company on or about February 13, 2012 against payment in immediately available funds.

Bank of America Merrill Lynch

Selling Agent


THE UNDERLYING INDEX

The Dow Jones-UBS Commodity IndexSM Total Return reflects the return on a fully collateralized investment in the Dow Jones-UBS Commodity IndexSM. See “The Underlying Indices—Dow Jones-UBS Commodity IndexSM” beginning on page S-31 of product supplement CLN-2 for information about the Underlying Index. CME Group Index Services LLC (“CME Indexes”) and UBS Securities LLC (“UBS Securities”) have no obligation to continue to publish, and may discontinue publication of, the Underlying Index. The consequences of CME Indexes and UBS Securities discontinuing publication of the Underlying Index are discussed in the section of product supplement CLN-2 entitled “Description of the Notes—Discontinuance of an Underlying Index” beginning on page S-28. None of us, the calculation agent, or MLPF&S accepts any responsibility for the calculation, maintenance, or publication of the Underlying Index or any successor index.

We have filed a registration statement (including a product supplement, a prospectus supplement, and a prospectus) with the SEC for the offering to which this term sheet relates. Before you invest, you should read the product supplement, the prospectus supplement, and the prospectus in that registration statement, and the other documents relating to this offering that we have filed with the SEC for more complete information about us and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, we, any agent, or any dealer participating in this offering will arrange to send you the product supplement, the prospectus supplement, and the prospectus if you so request by calling MLPF&S toll-free 1-866-500-5408.

 

PS-2